Genmab A/S (GNMSF)
320.00
+4.00
(+1.27%)
USD |
OTCM |
Dec 11, 13:17
Genmab Shareholders Equity (Quarterly): 5.751B for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Novo Nordisk A/S | 26.74B |
| Ascendis Pharma A/S | -204.54M |
| Evaxion AS | 10.34M |
| IO Biotech, Inc. | 0.911M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 7.021B |
| Total Liabilities (Quarterly) | 1.27B |
| Debt to Equity Ratio | 0.0247 |
| Current Ratio | 6.034 |
| Net Debt Paydown Yield | 0.00% |